Clinical Trial Update: Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating omega-3 fatty acids for indicated prevention in adolescents with at-risk mental state for psychosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prodrome
• Schizophrenia

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Medical University of Vienna | Conditions: Schizophrenia, Prodrome | Phase 4 | Status: COMPLETED